scholarly journals Efficacy and Safety of Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma after Autologous Stem Cell Transplantation: Secondary Analysis from the Phase 3 Aspire Study (NCT01080391)

2016 ◽  
Vol 22 (3) ◽  
pp. S66-S67 ◽  
Author(s):  
Parameswaran N. Hari ◽  
Kevin Song ◽  
William Bensinger ◽  
David Siegel ◽  
Faith Davies ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Secondary Analysis ◽  
Efficacy And Safety ◽  
Phase 3

scholarly journals Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Blood ◽  
2013 ◽  
Vol 121 (23) ◽  
pp. 4647-4654 ◽  
Author(s):  
Ulf-Henrik Mellqvist ◽  
Peter Gimsing ◽  
Oyvind Hjertner ◽  
Stig Lenhoff ◽  
Edward Laane ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Study Group ◽  
Phase 3 ◽  
Key Points

Key Points Bortezomib consolidation after ASCT improves PFS in myeloma. Improvement of response is seen with bortezomib consolidation after ASCT in myeloma.

Sign in / Sign up

Export Citation Format

Share Document